International AngiologyPub Date : 2024-06-01Epub Date: 2024-07-23DOI: 10.23736/S0392-9590.24.05143-5
Ahmet K Bozkurt, Ozan O Balkanay, Rasit Dinc
{"title":"Comparative analysis of VenaBlock and VenaSeal Systems for catheter-guided endovenous cyanoacrylate closure in treating chronic venous insufficiency of the lower extremity: effectiveness and feasibility.","authors":"Ahmet K Bozkurt, Ozan O Balkanay, Rasit Dinc","doi":"10.23736/S0392-9590.24.05143-5","DOIUrl":"10.23736/S0392-9590.24.05143-5","url":null,"abstract":"<p><p>Cyanoacrylate adhesive closure (CAC) systems are widely used to treat varicose veins. In terms of efficacy and safety, these nonthermal, non-tumescent methods are noninferior to endovenous thermal ablation techniques. However, no published studies have compared products that use CAC systems. VenaSeal<sup>®</sup> (Medtronic, Santa Rosa, CA, USA) and VenaBlock<sup>®</sup> (Invamed) are the most commonly used CAC-based products worldwide. This study aimed to focus on the efficacy of these two commonly used products, with little emphasis on safety. Published full-text articles on the VenaBlock<sup>®</sup> and VenaSeal<sup>®</sup> systems were searched. Data for each product were evaluated by comparing them with each other in terms of effectiveness. In total, 1882 extremities from 11 studies using VenaBlock<sup>®</sup> and 524 extremities from eight studies using VenaSeal<sup>®</sup> were included and compared. Both devices were effective, and their cumulative recanalization-free survival rates were similar (P=0.188) at the 6-, 12-, 24-, 36-, and 60-month follow-ups. Both products improved the venous clinical severity score (VCSS) and quality of life (QoL) scores. VenaBlock<sup>®</sup> and VenaSeal<sup>®</sup> are effective in terms of cumulative recanalization-free survival rates, and no significant difference was found between the two groups (P=0.188). Both significantly improve the VCSS and QoL scores. CAC is feasible for the treatment of varicose veins.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"331-341"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141748064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-06-01Epub Date: 2024-06-12DOI: 10.23736/S0392-9590.24.05170-8
Maxim E Shaydakov, Jose A Diaz, Bo Eklöf, Fedor Lurie
{"title":"Venous valve hypoxia as a possible mechanism of deep vein thrombosis: a scoping review.","authors":"Maxim E Shaydakov, Jose A Diaz, Bo Eklöf, Fedor Lurie","doi":"10.23736/S0392-9590.24.05170-8","DOIUrl":"10.23736/S0392-9590.24.05170-8","url":null,"abstract":"<p><strong>Introduction: </strong>The pathogenesis of deep vein thrombosis (DVT) has been explained by an interplay between a changed blood composition, vein wall alteration, and blood flow abnormalities. A comprehensive investigation of these components of DVT pathogenesis has substantially promoted our understanding of thrombogenesis in the venous system. Meanwhile, the process of DVT initiation remains obscure. This systematic review aims to collect, analyze, and synthesize the published evidence to propose hypoxia as a possible trigger of DVT.</p><p><strong>Evidence acquisition: </strong>An exhaustive literature search was conducted across multiple electronic databased including PubMed, EMBASE, Scopus, and Web of Science to identify studies pertinent to the research hypothesis. The search was aimed at exploring the connection between hypoxia, reoxygenation, and the initiation of deep vein thrombosis (DVT). The following key words were used: \"deep vein thrombosis,\" \"venous thrombosis,\" \"venous thromboembolism,\" \"hypoxia,\" \"reoxygenation,\" \"venous valve,\" and \"venous endothelium.\" Reviews, case reports, editorials, and letters were excluded.</p><p><strong>Evidence synthesis: </strong>Based on the systematic search outcome, 156 original papers relevant to the issue were selected for detailed review. These studies encompassed a range of experimental and observational clinical research, focusing on various aspects of DVT, including the anatomical, physiological, and cellular bases of the disease. A number of studies suggested limitations in the traditional understanding of Virchow's triad as an acceptable explanation for DVT initiation. Emerging evidence points to more complex interactions and additional factors that may be critical in the early stages of thrombogenesis. The role of venous valves has been recognized but remains underappreciated, with several studies indicating that these sites may act as primary loci for thrombus formation. A collection of studies describes the effects of hypoxia on venous endothelial cells at the cellular and molecular levels. Hypoxia influences several pathways that regulate endothelial cell permeability, inflammatory response, and procoagulation activity, underpinning the endothelial dysfunction noted in DVT.</p><p><strong>Conclusions: </strong>Hypoxia of the venous valve may serve as an independent hypothesis to outline the DVT triggering process. Further research projects in this field may discover new molecular pathways responsible for the disease and suggest new therapeutic targets.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"309-322"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141305893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-06-01Epub Date: 2024-07-22DOI: 10.23736/S0392-9590.24.05228-3
Filipa Jácome, Tiago Costa-Pereira, Ana Dionísio, Joel Sousa, Andreia Coelho, Armando Mansilha
{"title":"Contemporary open surgical approaches for the management of carotid stenosis: a comprehensive review.","authors":"Filipa Jácome, Tiago Costa-Pereira, Ana Dionísio, Joel Sousa, Andreia Coelho, Armando Mansilha","doi":"10.23736/S0392-9590.24.05228-3","DOIUrl":"10.23736/S0392-9590.24.05228-3","url":null,"abstract":"<p><p>This study aims to provide an overview on contemporary open surgical approaches for the management of carotid artery stenosis. A comprehensive literature search was performed to identify and categorize open surgery intervention techniques for the management of carotid artery stenosis, focusing on the benefits and drawbacks of each technique. Five surgical techniques for carotid endarterectomy (CEA) have been described: CEA with primary closure, CEA with patch closure, CEA by eversion technique, CEA by modified eversion technique and CEA by partial eversion. Evidence has reported significantly higher rates of perioperative complications after CEA with primary closure, including 30-days stroke rate and late restenosis. Although more recent techniques have been reported to provide superior outcomes, electing the best surgical technique is still a matter of debate. Also, CEA using a mini-skin incision has been associated to lower risk of cranial/cervical nerve injury and shorter length of hospital stay. The selection of the surgical intervention should be tailored and have into consideration individual patient characteristics, clinical considerations, surgeon preference and surgical team expertise. Further large-scale randomized clinical trials are needed to support more robust decisions on the choice of contemporary open surgical approaches to manage carotid stenosis.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"348-357"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141734035","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-06-01Epub Date: 2024-07-24DOI: 10.23736/S0392-9590.24.05241-6
Pavel Poredoš, Kosmas I Paraskevas, Dimitri P Mikhailidis, Agata Stanek, Arkadiusz Jawien, Pier Luigi Antignani, Ales Blinc
{"title":"Specificities of primary and secondary prevention of lower extremity artery disease: introduction to a series of reviews.","authors":"Pavel Poredoš, Kosmas I Paraskevas, Dimitri P Mikhailidis, Agata Stanek, Arkadiusz Jawien, Pier Luigi Antignani, Ales Blinc","doi":"10.23736/S0392-9590.24.05241-6","DOIUrl":"10.23736/S0392-9590.24.05241-6","url":null,"abstract":"<p><p>This article briefly discusses the risk factors for the development of lower extremity artery disease, namely smoking, diabetes mellitus, hyperlipidemia/dyslipidemia and hypertension. Each of these risk factors will be discussed in detail in forthcoming articles of the journal.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"374-377"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-06-01Epub Date: 2024-07-24DOI: 10.23736/S0392-9590.24.05174-5
Daisuke Akagi, Kai Murase, Atsushi Tabuchi
{"title":"Relationship between body figure and stump length in cyanoacrylate closure of varicose veins.","authors":"Daisuke Akagi, Kai Murase, Atsushi Tabuchi","doi":"10.23736/S0392-9590.24.05174-5","DOIUrl":"10.23736/S0392-9590.24.05174-5","url":null,"abstract":"<p><strong>Background: </strong>Recurrence of incompetent saphenous veins after treatment is associated with remnant reflux to the branches close to the saphenofemoral or saphenopopliteal junctions, which originate from the residual patent stump after saphenous vein treatment. This study aimed to determine the factors affecting residual stump length after cyanoacrylate closure.</p><p><strong>Methods: </strong>This retrospective study used prospectively collected data of patients who underwent cyanoacrylate closure. Postoperative Duplex scanning was performed to evaluate occlusion of the target vein, stump length, and the presence of endovenous glue-induced thrombosis. The clinical outcomes and patient characteristics were also evaluated.</p><p><strong>Results: </strong>Seventy procedures for incompetent saphenous veins were performed in 67 limbs of 47 patients. The average patient age was 43 (range, 43-89) years; 34 (72%) were female patients. Target vein occlusion was achieved in all patients and endovenous glue-induced thrombosis occurred in 1.5 % of patients. The mean stump length was 18.3 mm. Total occlusion from the junction was observed in 13 vessels (19%). Particularly, higher total occlusion rate was found in treatments of the small saphenous vein compared with those of the great saphenous vein (GSV). In 6 GSV treatments, longer stumps (>45 mm) remained. Those with a stump >45 mm were all female patients, with significantly shorter height and higher Body Mass Index compared with those with stump lengths <45 mm.</p><p><strong>Conclusions: </strong>Body figure should be considered when performing cyanoacrylate closure to treat insufficient saphenous varicose veins. However, further investigations are to be warranted.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"342-347"},"PeriodicalIF":1.5,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141751631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"RIvaroxaban and VAscular Surgery (RIVAS): insights from a multicenter, worldwide web-based survey.","authors":"Nicola Troisi, Giulia Bertagna, Raffaella Berchiolli","doi":"10.23736/S0392-9590.24.05146-0","DOIUrl":"10.23736/S0392-9590.24.05146-0","url":null,"abstract":"","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"306-308"},"PeriodicalIF":1.5,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139650708","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-04-01Epub Date: 2024-04-12DOI: 10.23736/S0392-9590.24.05142-3
Shangtong Jiang, Yue Liu, Jinbo Liu, Gaoqiang Xie, Hongwei Zhao, Na Zhao, Hongyu Wang
{"title":"The characteristics of arterial risk factors and ankle-brachial index in patients with lower extremity chronic venous diseases: results from the BEST study.","authors":"Shangtong Jiang, Yue Liu, Jinbo Liu, Gaoqiang Xie, Hongwei Zhao, Na Zhao, Hongyu Wang","doi":"10.23736/S0392-9590.24.05142-3","DOIUrl":"10.23736/S0392-9590.24.05142-3","url":null,"abstract":"<p><strong>Background: </strong>The aim of our study was to explore the characteristics of the arterial risk factors and ankle-brachial index (ABI) in patients with lower extremity chronic venous disease (LECVD).</p><p><strong>Methods: </strong>A total of 2642 subjects were employed in our study. The lifestyle and clinical data were collected. The history of vascular diseases contained coronary artery disease, stroke, hypertension, and diabetes. ABI low than 0.9 was considered as lower extremity artery disease (LEAD). A series of blood indicators were measured.</p><p><strong>Results: </strong>Patients with ABI low than 0.9 belonged to the group of LEAD. Age, smoking, drinking, hypertension, diabetes mellitus, lipid-lowering drug, antidiabetic, total protein, total protein, triglyceride, low-density lipoprotein cholesterol, glycosylated hemoglobin and homocysteine were the common risk factors shared by LEAD and LECVD (P<0.05). The prevalence of LEAD in patients with LECVD was higher than those without LECVD (P<0.05). In Pearson correlation analysis, LECVD was related to LEAD (P<0.05). Before and after adjusted shared factors, as the performance of the logistic regression models, LEAD was an independent risk factor for the prevalence of LECVD (OR=2.937, 95% CI: [1.956, 4.411], P<0.001).</p><p><strong>Conclusions: </strong>Our study demonstrated that an ABI lower than 0.9 is an independent risk factor for LECVD.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"240-246"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856305","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-04-01Epub Date: 2024-04-04DOI: 10.23736/S0392-9590.24.05112-5
Mesut Karatas, Kemal E Parsova, Muhammed Keskin, Lutfi Ocal, Selami Doğan, Nursen Keles
{"title":"Prognostic value of serum albumin to creatinine ratio in patients undergoing carotid artery stenting.","authors":"Mesut Karatas, Kemal E Parsova, Muhammed Keskin, Lutfi Ocal, Selami Doğan, Nursen Keles","doi":"10.23736/S0392-9590.24.05112-5","DOIUrl":"10.23736/S0392-9590.24.05112-5","url":null,"abstract":"<p><strong>Background: </strong>We aimed to investigate the prognostic value of serum albumin-to-creatinine ratio (sACR) in carotid artery stenting (CAS) patients regarding in-hospital and 5-year outcomes.</p><p><strong>Methods: </strong>This is a retrospective study. Baseline characteristics were compared between patients by admission albumin to creatinine ratio and categorized accordingly: T1, T2 and T3. 609 patients were included in the study. Serum albumin and creatinine levels at hospital admission were used to calculate the sACR. The primary endpoint was all-cause mortality. MACE consisted of stroke, transient ischemic attack (TIA), myocardial infarction (MI) and death. All follow-up data were obtained from electronic medical records or by interview. The study was terminated after 60 months of follow-up.</p><p><strong>Results: </strong>Serum albumin levels were found to be significantly lower in T1, while creatinine was found to be significantly higher in T1. T1 has the lowest sACR while T3 has the highest. In hospital, ipsilateral stroke, major stroke, MI and death were significantly higher in T1. In long-term outcomes, ipsilateral stroke, major stroke, and death were significantly higher in T1.</p><p><strong>Conclusions: </strong>Low sACR values at hospital admission was independently associated with in-hospital and long-term mortality and major stroke in patients underwent CAS.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"290-297"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140859535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-04-01Epub Date: 2024-03-19DOI: 10.23736/S0392-9590.24.05153-8
Nicola Cicala, Paolo Perini, Alexandra Catasta, Anna Fornasari, Alessandro Ucci, Antonio Freyrie
{"title":"Systematic review and meta-analysis of incidence, indications, and outcomes of early open conversions after EVAR for abdominal aortic aneurysms.","authors":"Nicola Cicala, Paolo Perini, Alexandra Catasta, Anna Fornasari, Alessandro Ucci, Antonio Freyrie","doi":"10.23736/S0392-9590.24.05153-8","DOIUrl":"10.23736/S0392-9590.24.05153-8","url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this study is to report incidence, indications, and outcomes of early open conversions (EOC) after endovascular aortic repair (EVAR), defined as surgical conversion performed within 30 days from the initial EVAR.</p><p><strong>Evidence aquisition: </strong>A systematic review of the literature was performed (database searched: PubMed, Web of Science, Scopus, Cochrane Library; last search April 2023). Articles reporting EOC after EVAR comprising at least five patients were included. Meta-analyses of proportions were performed using a random-effects model.</p><p><strong>Evidence synthesis: </strong>Seventeen non-randomized studies, published between 1999 and 2022, were included. A total of 35,970 patients had previously undergone EVAR, of these 438 patients underwent EOC. Estimated incidence of EOC was 1.4% (95% CI 1.1-1.4; I<sup>2</sup>=81.66%). Specifically, in the works published before 2010 the incidence was 1.8% (95% CI 1.3-2.4; I<sup>2</sup>=74.25) while for subsequent ones it was 0.9% (95% CI 0.6-1.1; I<sup>2</sup>=69.82). Weighted mean age was 74.91 years (95% CI 72.42-77.39; I<sup>2</sup>=83.11%). Estimated rate of cause determining EOC were: access issue in 27.7% of patients (95% CI 13.8-41.6; I<sup>2</sup>=88.14%), incorrect placement of the endograft in 20.1% (95% CI 10.2-30.0; I<sup>2</sup>=76,9%), problems with \"delivery system\" in 9.0% (95% CI 4.9-13.1; I<sup>2</sup>=0%), aorto-iliac rupture in 8.6% (95% CI 4.5-12.6; I<sup>2</sup>=0%), endoprosthesis migration in 7.9% of cases (95% CI 3.3-12.4; I<sup>2</sup>=22.96%), failure in engaging the contralateral gate in 4.8% (95% CI 1.6-8; I<sup>2</sup>=0%), \"kinking\" or \"twisting\" of endoprosthesis in 3.3% (95% CI 0.6-5.9; I<sup>2</sup>=0%), graft thrombosis in 3.2% (95% CI 0.6-5.7; I<sup>2</sup>=0%), type Ia endoleak in 2.9% (95% CI 0.4-5.4; I<sup>2</sup>=0%), type III endoleak in 2.8% (95% CI 0.3-5.3; I<sup>2</sup>=0%) and endograft infection in 2.7% (95% CI 0.3-5.2; I<sup>2</sup>=0%). Intraoperative conversion rate was 91.1% (95% CI 85.8-96.4; I<sup>2</sup>=66.01%). Early mortality rate after EOC was 14.5% (95% CI 9.1-19.9; I<sup>2</sup>=48.31%). Mean length of stay (LOS) was 11.94 days (95% CI 6.718-17.172; I<sup>2</sup>=92.34%).</p><p><strong>Conclusions: </strong>The incidence of EOC seems to decrease over time. Causes of EOC were mainly related to access problems and incorrect positioning of the endograft. Most of the EOC were performed intraoperatively carrying a high mortality rate.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"271-279"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140174539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
International AngiologyPub Date : 2024-04-01Epub Date: 2024-04-12DOI: 10.23736/S0392-9590.24.05041-7
Paul J Choi, Mahmood Kabeil, Pedro J Furtado Neves, Nicos Labropoulos, Ahsan Zil-E-Ali, Faisal Aziz, Emily A Malgor, Rafael D Malgor
{"title":"Urological complications caused by inferior vena cava filters: a systematic review.","authors":"Paul J Choi, Mahmood Kabeil, Pedro J Furtado Neves, Nicos Labropoulos, Ahsan Zil-E-Ali, Faisal Aziz, Emily A Malgor, Rafael D Malgor","doi":"10.23736/S0392-9590.24.05041-7","DOIUrl":"10.23736/S0392-9590.24.05041-7","url":null,"abstract":"<p><strong>Introduction: </strong>Inferior vena cava (IVC) filters act in preventing pulmonary embolisms (PE). Various complications have been reported with their use. However, a credible urological complication rate, filter characteristics, and clinical presentation has yet to be summarized. Thus, we reported these complications in the form of a systematic review.</p><p><strong>Evidence acquisition: </strong>A search strategy was designed using PubMed, MEDLINE, and EMBASE on February 10<sup>th</sup>, 2022. The design of this search strategy did not include any language restrictions. The key words (and wildcard terms) used in the search strategy were urolog*, ureter*, bladder, kidney coupled with filter, inferior vena cava, and cava*. Inclusion criteria were: patients older than 18, with previous IVC filter placement, and urologic complication reported. Exclusion criteria were: patients younger than 18, no IVC filter placement, and no urologic complication reported. Other case series and reviews were excluded to avoid patient duplication.</p><p><strong>Evidence synthesis: </strong>Thirty-five articles were selected for full-text screening. Thirty-seven patient cases were reviewed, and the median age was 53 (range: 21-92 years old). Abdominal and or flank pain was reported in 16 (43%) patients, hematuria was seen in eight (22%) and two (5%) patients died due to acute renal failure resulting from the urologic complications of the IVC filter. Indications for IVC filter placement were recurrent pulmonary embolism (PE), contraindication to or noncompliance with anticoagulant therapy. The IVC filters were infrarenal in 29 (78.4%) patients, suprarenal in five (13.5%) patients, not reported in two patients, and misplaced into the right ovarian vein in one patient. Three or more imaging modalities were obtained in 19 patients (51%) for planning. IVC filter removal was not performed in 17 (45.9%) patients, endovascular retrieval occurred in nine (24.3%) patients, and open removal was performed in seven (18.9%) patients, and tissue interposition was performed in two (5.4%) patients. One patient did not have the management reported.</p><p><strong>Conclusions: </strong>Urological complications caused by IVC filters although rare, are likely underreported, require extensive workup, and pose surgical challenges. Due to their complex management, filter retrieval should be planned for as soon as feasible, and plans should be made as early as during the IVC filter implant. For those that do develop complications, clinical judgement must be exercised in management, and open surgical, endovascular or even conservative management strategies can be viable options and should be discussed in a multidisciplinary setting.</p>","PeriodicalId":13709,"journal":{"name":"International Angiology","volume":" ","pages":"247-254"},"PeriodicalIF":1.4,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140855218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}